Revision history of "AAP RESEARCH AND SOCIETES 2017/BiomarkersMETCP — Search for biomarkers and therapeutic targets for carboplatin-treated lung cancer using an approach integrating the tumour microenvironment" (Q3679421)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 11:2711:27, 11 October 2024DG Regio talk contribs 66,324 bytes +15 Changed label, description and/or aliases in pt
  • curprev 11:2711:27, 11 October 2024DG Regio talk contribs 66,309 bytes +4 Set a claim value: summary (P836): O cancro do pulmão mata um milhão de pessoas todos os anos em todo o mundo e o aparecimento frequente de resistência ao principal tratamento básico, compostos de platina, deixa muitos pacientes sem opção terapêutica real. O tumor mais comum (~40 %) é o adenocarcinoma (Luad) e, quando este último é causado por uma mutação do gene KRAS (~30 % dos casos), não existe tratamento direcionado. O projeto visa procurar biomarcadores e alvos terapêuticos para...

22 March 2024

12 January 2024

19 June 2023

11 June 2023

8 June 2023

11 August 2022

  • curprev 15:5815:58, 11 August 2022DG Regio talk contribs 63,045 bytes +43,628 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

14 January 2022

13 January 2022

6 December 2021

1 December 2021

  • curprev 07:4707:47, 1 December 2021DG Regio talk contribs 12,534 bytes +1,965 Created claim: summary (P836): Lungenkrebs tötet jährlich eine Million Menschen weltweit, und die häufige Entstehung von Resistenz gegen die primäre Grundbehandlung, Platinverbindungen, hinterlässt viele Patienten ohne echte therapeutische Option. Der häufigste Tumor (~40 %) ist das Adenokarzinom (Luad), und wenn es durch eine Mutation des KRAS-Gens verursacht wird (~30 % der Fälle), gibt es keine gezielte Behandlung. Ziel des Projekts ist die Erforschung von Biomarkern und t...

27 November 2021

  • curprev 13:0213:02, 27 November 2021DG Regio talk contribs 10,569 bytes −2,077 Removed claim: summary (P836): Le cancer du poumon tue un million de personnes chaque année dans le monde et l’émergence fréquente de résistance au traitement de base principal, les composés du platine, laisse de nombreux patients sans véritable option thérapeutique. La tumeur la plus commune (~40 %) est l‚adénocarcinome (LUAD) et lorsque ce dernier est causé par une mutation du gène KRAS, (~30 % des cas), il n‘existe pas de traitement ciblé. Le projet vise à rechercher des...

26 November 2021

  • curprev 23:1723:17, 26 November 2021DG Regio talk contribs 12,646 bytes +2,077 Created claim: summary (P836): Le cancer du poumon tue un million de personnes chaque année dans le monde et l’émergence fréquente de résistance au traitement de base principal, les composés du platine, laisse de nombreux patients sans véritable option thérapeutique. La tumeur la plus commune (~40 %) est l‚adénocarcinome (LUAD) et lorsque ce dernier est causé par une mutation du gène KRAS, (~30 % des cas), il n‘existe pas de traitement ciblé. Le projet vise à rechercher des b...
  • curprev 14:4614:46, 26 November 2021DG Regio talk contribs 10,569 bytes +269 Changed label, description and/or aliases in de: translated_label

24 November 2021

18 November 2021

  • curprev 17:0117:01, 18 November 2021DG Regio talk contribs 9,869 bytes +250 Changed label, description and/or aliases in en: translated_label
  • curprev 17:0117:01, 18 November 2021DG Regio talk contribs 9,619 bytes +1,929 Created claim: summary (P836): Lung cancer kills one million people every year around the world and the frequent emergence of resistance to the main basic treatment, platinum compounds, leaves many patients with no real therapeutic option. The most common tumour (~40 %) is adenocarcinoma (Luad) and when the latter is caused by a mutation of the KRAS gene (~30 % of cases), there is no targeted treatment. The project aims to search for biomarkers and therapeutic targets for lun...

17 November 2021